Search
for
Sort by
Research 871–900 of 1000+
- A PAX1 enhancer locus is associated with susceptibility to idiopathic scoliosis in females
- 5α‐Reductase Isozymes and Androgen Actions in the Prostate
- Congenital Adrenal Hyperplasia
- `A Dubious Equality': Men, Women and Cosmetic Surgery
- Neurosteroids, neuroactive steroids, and symptoms of affective disorders
- Adverse effects of common medications on male fertility
- Emerging medication for the treatment of male hypogonadism
- Testosterone Metabolism in the Skin
- Physiology of the Hypothalamic Pituitary Gonadal Axis in the Male
- Prospective investigation of risk factors for prostate cancer in the UK Biobank cohort study
- The prevalence and management of side effects of lithium and anticonvulsants as mood stabilizers in bipolar disorder from a clinical perspective
- Male pattern hair loss: current understanding
- Liver and Kidney Dysfunction in Wistar Rats Exposed to Municipal Landfill Leachate
- Menopause and aging, quality of life and sexuality
- STEROIDS AND STEROID-LIKE COMPOUNDS
- Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome
- A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive.
- Safety Analysis of Panax Ginseng in Randomized Clinical Trials: A Systematic Review
- Dutasteride
- Mood disorders and quality of life in polycystic ovary syndrome
- Androgens and Antiandrogens
- Five-alpha-reductase Inhibitors for prostate cancer prevention.
- Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study
- Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
- Treatment options for alopecia: an update, looking to the future
- Epitestosterone—an endogenous antiandrogen?
- Ejaculations and Benign Prostatic Hyperplasia: An Impossible Compromise? A Comprehensive Review
- Endocrine correlates of male breast cancer risk: a case-control study in Athens, Greece
- Improvement in androgenetic alopecia in 53-76-year-old men using oral finasteride
- Key targets of hormonal treatment of prostate cancer. Part 2: the androgen receptor and 5α-reductase